HETEROARYL SULTAM DERIVATIVES AS RORc MODULATORS
    8.
    发明申请
    HETEROARYL SULTAM DERIVATIVES AS RORc MODULATORS 审中-公开
    作为RORC调制器的HETEROARYL SULTAM衍生物

    公开(公告)号:US20160311817A1

    公开(公告)日:2016-10-27

    申请号:US15202911

    申请日:2016-07-06

    申请人: Genentech, Inc.

    IPC分类号: C07D417/14 C07D417/04

    摘要: Compounds of the formula I or a pharmaceutical salt thereof, wherein m, n, q, r, A, W, X1, X2, X3, X4, Y, Z, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 and R11 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of inflammatory diseases such as arthritis.

    摘要翻译: 或其药物盐,其中m,n,q,r,A,W,X1,X2,X3,X4,Y,Z,R1,R2,R3,R4,R5,R6,R7,R8,R9,R10 和R 11如本文所定义。 还公开了制备化合物和使用该化合物治疗炎性疾病如关节炎的方法。

    KETO-IMIDAZOPYRIDINE DERIVATIVES AS RORc MODULATORS
    9.
    发明申请
    KETO-IMIDAZOPYRIDINE DERIVATIVES AS RORc MODULATORS 审中-公开
    作为RORc调节剂的酮咪唑吡啶衍生物

    公开(公告)号:US20160272631A1

    公开(公告)日:2016-09-22

    申请号:US14481991

    申请日:2014-09-10

    申请人: Genentech, Inc.

    IPC分类号: C07D471/04 C07D487/04

    CPC分类号: C07D471/04 C07D487/04

    摘要: Compounds of the formula I or II: or pharmaceutically acceptable salts thereof, wherein R1 is a group of formula (a), (b), (c); (d) or (e): and m, n, X, Y, R1, R2, R3, R4, Rb and Rc are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of inflammatory diseases such as arthritis.

    摘要翻译: 并且m,n,X,Y,R 1,R 2,R 3,R 4,R b和R c如本文所定义。 还公开了制备化合物和使用该化合物治疗炎性疾病如关节炎的方法。